BGI Genomics (300676) Stock Price, News, Quotes-Moomoo

CN Stock MarketDetailed Quotes

300676 BGI Genomics

Watchlist

46.62
+0.62+1.35%

Market Closed Nov 19 15:00 CST

19.39BMarket Cap-191065P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Health Check: How Prudently Does BGI Genomics (SZSE:300676) Use Debt?
Simply Wall StNov 17 19:17 ET
Asia-Pacific Metagenomics Market Research 2024-2033 With Competitive Analysis of Leading Players - BGI Genomics, MGI Tech, and Macrogen - ResearchAndMarkets.com
BusinesswireNov 8 07:51 ET
BGI: Report for the third quarter of 2024
SZSIOct 25 12:00 ET · Announcements
BGI Genomics Co., Ltd.'s (SZSE:300676) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Simply Wall StOct 21 23:19 ET
BGI Genomics' (SZSE:300676 Three-year Decrease in Earnings Delivers Investors With a 62% Loss
Simply Wall StSep 16 19:16 ET
BGI Genomics Gets Registration for Expanded Use of Hereditary Deafness Gene Detection Kit
MT NewswiresSep 13 00:42 ET

Comments

Moomoo AI

Feb 21 16:26

BGI Genomics' low ROE and net income growth are worrisome. Despite high reinvestment, the low ROE indicates that it's not benefiting investors and is hampering earnings growth. Caution is advised due to these factors.

Are BGI Genomics Co., Ltd.'s (SZSE:300676) Mixed Financials Driving The Negative Sentiment?

Spinee

Jan 28 19:47

A bill to prohibit contracting with certain biotechnology providers, and for other purposes.

BGI, MGI, Complete Genomics, Wuxi Apptec, and any subsidiary are included.
Last Friday, WuXi AppTec's shares tumble by 20% in Hong Kong and fall by a 10% limit-down in mainland China.
Other CRO stocks including Medicilon are also falling.
$WUXI BIO (02269.HK)$ $WUXI APPTEC (02359.HK)$ $BGI Genomics (300676.SZ)$ $MGI Tech Co., Ltd. (688114.SH)$ $Shanghai Medicilon Inc. (688202.SH)$ $Novo-Nordisk A/S (NVO.US)$ $Hang Seng H-Share Index ETF (02828.HK)$

Moomoo AI

Jan 24 18:28

Despite a significant drop in BGI Genomics' EPS and share price, the market still sees a promising future, as indicated by its high P/E ratio. Investors should monitor the company's fundamentals and be vigilant for warning signs.

Investors in BGI Genomics (SZSE:300676) Have Unfortunately Lost 73% Over the Last Three Years

Moomoo AI

Jan 1 19:19

Investors currently view BGI Genomics as an underperforming company, largely influenced by its poor revenue growth over the past years. Its P/S ratio may tumble further if the company fails to improve its revenue growth, leading to further investor disappointment.

Improved Revenues Required Before BGI Genomics Co., Ltd. (SZSE:300676) Shares Find Their Feet

Moomoo AI

Nov 20, 2023 17:32

BGI Genomics' low ROE and limited earnings growth, despite high profit retention, raise concerns about its financial performance and efficient use of equity capital and profits. The current price momentum may not be sustainable.

BGI Genomics Co., Ltd.'s (SZSE:300676) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

300676 BGI Genomics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target